Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning by cytarabine |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cytarabine poisoning (disorder) |
Causative agent (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional cytarabine poisoning |
Causative agent (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la cytarabine d'intention indéterminée |
Causative agent (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine adverse reaction |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine allergy |
Causative agent (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine overdose |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cytarabine overdose |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cytarabine overdose (disorder) |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de cytarabine d'intention indéterminée |
Causative agent (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 500mg/5mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 20mg/mL injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/5mL injection solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/10mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 10mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine liposomal 50mg/5mL injection 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cytarabine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 500mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 2g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 50 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine liposome |
Is a |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental cytarabine poisoning (disorder) |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cytarabine poisoning |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine allergy |
Causative agent (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cytarabine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine liposome |
Is modification of (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cytarabine 1 gram/10 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 1 gram/10 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cytarabine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 20 mg/mL solution for injection |
Has precise active ingredient |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 20 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 50 mg/mL suspension for injection |
Has precise active ingredient |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 50 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 500 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytarabine and daunorubicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cytarabine- and daunorubicin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytarabine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |